Cells Sell: Your Company Can't Ignore Biotech

Karl and Erum dig into the pivotal role of bio strategy in shaping the future of consumer products and sustainability. With insights into groundbreaking innovations—from Cresalon's trauma gel gaining FDA approval to Living Ink's partnership with New Balance—this discussion explores how biotech is transforming traditional industries. We also tackle the challenges of scaling bio-manufacturing, reducing costs, and navigating regulatory landscapes, all while highlighting the critical importance of integrating biology into corporate strategies. Join us as we uncover why now is the time for every company to adopt a bio strategy.

Chapters

• 00:00:00 - Kicking Off Biotech’s Role

• 00:00:15 - Breakthrough Biotech Innovations

• 00:02:26 - Living Ink’s Sustainable Success

• 00:04:25 - Tandem Repeat’s Scalable Fibers

• 00:05:45 - The Power of Biostrategy

• 00:06:44 - Overcoming Biotech Challenges

• 00:16:19 - Scaling and Regulation in Biotech

• 00:23:17 - Transforming Supply Chains with Biotech

• 00:30:45 - Biotech’s Impact on Consumer Goods

• 00:42:23 - The Future of Biotech in Products

• 00:43:45 - Final Thoughts and Next Steps

Topics Covered: biotech, bioengineering, biostrategy, consumer biotech, consumer products and goods  

Episode Links

Report: 80% of consumers are very or somewhat concerned about the environmental impact of the products they buy

Report: 75% of consumer product organizations and retailers turn to regional sourcing amidst global disruption

The CHIPS and Science Act

Mosa Meat holds first official EU tasting of cultivated beef

Episode 73: At the Bleeding Edge: Cresilon's Joe Landolina on Rapid Wound Care

Episode 71: Squid Pro Quo: Tandem Repeat's Melik Demirel Reinvents Clothing with Squitex